SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant

26 Jul 2021 Evaluate

Kilitch Drugs India has started production of the Cephalosporin Injectables at Ethiopia manufacturing plant. The company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant.

In early 2021 the company has started production of Antiseptic and Disinfectant products to help Ethiopia fight against the COVID-19 pandemic.

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms.

Kilitch Drugs(India) Share Price

151.55 -8.40 (-5.25%)
24-Apr-2026 13:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.35
Dr. Reddys Lab 1321.90
Cipla 1300.00
Zydus Lifesciences 929.75
Lupin 2276.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×